11 – 20 of 143
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2022
-
Mark
Dynamically upregulated mast cell CPA3 patterns in chronic obstructive pulmonary disease and idiopathic pulmonary fibrosis
(
- Contribution to journal › Article
-
Mark
Pulmonary Embolism : Ventilation/Perfusion Scintigraphy as a Proper Tool in Diagnosing Pulmonary Embolism and Frequent Pulmonary Comorbidities
(
- Chapter in Book/Report/Conference proceeding › Book chapter
- 2021
-
Mark
Fibroblast growth factor 23 is an independent marker of COPD and is associated with impairment of pulmonary function and diffusing capacity
(
- Contribution to journal › Article
-
Mark
A new protocol for exercise testing in COPD; improved prediction algorithm for WMAX and validation of the endurance test in a placebo-controlled double bronchodilator study
(
- Contribution to journal › Article
-
Mark
Efficacy and Safety of Umeclidinium/Vilanterol in Current and Former Smokers with COPD : A Prespecified Analysis of The EMAX Trial
(
- Contribution to journal › Article
-
Mark
How to assess breathlessness in chronic obstructive pulmonary disease
(
- Contribution to journal › Article
-
Mark
The ratio FEV1/FVC and its association to respiratory symptoms—A Swedish general population study
(
- Contribution to journal › Article
-
Mark
Severe alpha-1-antitrypsin deficiency increases the risk of venous thromboembolism
(
- Contribution to journal › Article
-
Mark
Hypoxemia severity and survival in ILD and COPD on long-term oxygen therapy – The population-based DISCOVERY study
(
- Contribution to journal › Article
-
Mark
Efficacy of umeclidinium/vilanterol according to the degree of reversibility of airflow limitation at screening : a post hoc analysis of the EMAX trial
(
- Contribution to journal › Article